Risk factors for multi-drug resistant P. aeruginosa

Identifying the Leading Risk Factors for Acquiring VIM-2 Positive Pseudomonas aeruginosa – a Case Control Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24496

Enrollment

140

Registered

2015-03-23

Start date

2015-03-25

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VIM-2 positive Pseudomonas aeruginosa Healthcare-related/Gezondheidszorg gerelateerd Multi-drug resistant/multiresistent Risk factors/Risicofactoren

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • VIM-2 positive culture after 48 hours after admittance in the Erasmus University Medidcal Center.

Exclusion criteria

Exclusion criteria: • Children, because they are admitted at the Sophia Children’s Hospital and are separated from the Erasmus MC facilities. To our knowledge, there is no evidential cross-over potential of VIM-2 positive P. aeruginosa to the adult-care facilities. • The outbreak resulting from Endoscopic Retrograde Cholangiopancreatography (ERCP). This outbreak has a known cause and is therefore reported and investigated separately (21). • Patients only admitted at the Erasmus MC Cancer Institute . These patients are cared for in a separate building of the Erasmus MC and are therefore not be included in this study.

Design outcomes

Primary

Measure	Time frame
VIM-2 positive culture of P. auruginosa (infection or colonization) Absence of VIM-2 positive P. auruginosa (infection or colonization)/culture of P. auruginosa (infection or colonization)	—

Secondary

Measure	Time frame
Not appliacble	—

Contacts

Public ContactMargreet C. Vos

Erasmus Medisch Centrum Rotterdam - Department of Medical Microbiology & Infectious diseases

m.vos@erasmusmc.nl0107033510

Outcome results